Good morning :)
$
₹
HeartSciences Inc.

HeartSciences Inc.

HSCS

NASDAQ
Asset Logo

HeartSciences Inc.

HSCS

NASDAQ
$3.063.76% (+0.11)
$
₹
$3.063.76% (+0.11)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Micro Cap

With a market cap of $14.9M the stock is ranked 5568

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

70.84
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-3.21
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 1 analyst's reports

Buy
1 analyst
Hold
0 analyst
Sell
0 analyst

Price Upside

+306.78%

Earnings Growth

+37.56%

Rev. Growth

+295.92%

See Detailed Forecast

Company Profile

Company Profile

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
40.95
40.95
1Y Return
13.03%
13.03%
Buy Reco %
82.14
82.14
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
37.74
37.74
1Y Return
7.61%
7.61%
Buy Reco %
83.33
83.33
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
52.82
52.82
1Y Return
10.52%
10.52%
Buy Reco %
76.47
76.47
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
23.69
23.69
1Y Return
16.08%
16.08%
Buy Reco %
66.66
66.66
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
32.67
32.67
1Y Return
6.33%
6.33%
Buy Reco %
76.66
76.66
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 306.78% growth, versus a trailing 3-year CAGR of -43.20%.

2026
Current$2.95Baseline
Analyst Target - 1 year
Target$12+306.78%

All values in $

202220232024202520262027$25.09$47.53$69.96Target+306.78%
2026
Current$2.95Baseline
Analyst Target - 1 year
Target$12+306.78%

All values in $

Revenue Forecast

Revenue Forecast

Higher revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 295.92% growth, versus a trailing 3-year CAGR of -5.70%.

2026
Current$4.31Baseline
Forecast for Apr 2027
High$17.1+295.92%
Average$17.1+295.92%
Low$17.1+295.92%

All values in $ Thousand

20222023202420252026202714.375.1518.64.354.31Low+295.92%Average+295.92%High+295.92%
2026
Current$4.31Baseline
Forecast for Apr 2027
High$17.1+295.92%
Average$17.1+295.92%
Low$17.1+295.92%

All values in $ Thousand

Earnings Per Share Forecast

Earnings Per Share Forecast

2026
Current$-3.94Baseline
Forecast for Apr 2027
High$-2.46+37.56%
Average$-2.46+37.56%
Low$-2.46+37.56%

All values in $

202220232024202520262027-0.35-57.46-50.81-9.36-3.94Low+37.56%Average+37.56%High+37.56%
2026
Current$-3.94Baseline
Forecast for Apr 2027
High$-2.46+37.56%
Average$-2.46+37.56%
Low$-2.46+37.56%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

0
-2.3
-1.9
89.4
-2.7
0
-3.1
Q4 2025
Q1 2026
Q2 2026
Q3 2026
Revenue
Net Income
Financial YearQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Total Revenue0000000089.490
Net Income-1.84-2.05-2.08-2.53-2.09-2.05-2.35-1.98-2.75-3.17
Net Profit Margin-----48145.49%-108157.57%-97179.37%--3.07%-151064%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
HeartSciences Inc. -70.84-
Abbott Laboratories40.953.591.51
Danaher Corporation37.743.041.32
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare HSCS with any stock or ETF
Compare HSCS with any stock or ETF
Comparing from
HSCS
ABT
DHR
Loading...

Frequently asked questions

  1. HeartSciences Inc. (HSCS) share price today is $3.06 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $3.34 and a day low of $3.00.

  2. HeartSciences Inc. stock trades on NASDAQ under the ticker symbol HSCS.

  3. HeartSciences Inc.'s market capitalization is $14.85M as of November 5, 2026 at 2:29 AM IST.

  4. HeartSciences Inc.'s price-to-earnings (P/E) ratio is N/A as of November 4, 2026.

  5. HeartSciences Inc.'s price-to-book (P/B) ratio is 70.84 as of November 4, 2026.

  6. Yes, You can buy HeartSciences Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy HeartSciences Inc. shares in three steps: 1. Search HeartSciences Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since HeartSciences Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in HeartSciences Inc. (HSCS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 3.2669 shares at the current price of $3.06.

Loading...